Psoriasis

July 30, 2018

Here’s a brief look at medications for rheumatologic disorders that were approved or granted a new indication in 2018.

July 12, 2018

New recommendations from the National Psoriasis Foundation offer answers. The express goal of these guidelines: to reduce disease severity through proper nutrition.

July 09, 2018

Two recent studies focus on the risks of osteoporosis and cardiovascular disease in patients on the psoriatic arthritis/psoriasis spectrum.

June 19, 2018

A diagnostic challenge: foot and ankle tendinopathy or enthesopathy in patients with psoriasis who do not have psoriatic arthritis.

May 29, 2018

The approval makes Cimzia the first Fc-free, PEGylated anti-TNF treatment option for this indication.

April 30, 2018

Most patients seen in primary care have mild to moderate plaque psoriasis, which is usually treatable with topical therapies.

March 23, 2018

This novel interleukin-23 inhibitor targets psoriatic inflammation.

March 20, 2018

Help your patients help themselves. Take a look at 6 rheumatology apps you can discuss at the next visit.

March 12, 2018

In late-breaking clinical trials, 3 novel biologic drugs show promise for the treatment of moderate to severe plaque psoriasis.

February 21, 2018

Another potential indication for medical marijuana: psoriasis.